Data privacy Data protection We are pleased about your visit to our website. In the following, we will inform you about which personal data we collect and what happens to this data when you visit our
History Foundation and development of the NMI The state needs more application orientation The impetus for founding the NMI came in 1983 from Dr. Günter Hoff, head of research in the "New Technologies
The collaborative project FoBioGel aims at the development of photo-structurable, biochemically functionalizable hydrogels in the sense of a technology platform. These hydrogels are to be used as a bi
The aim of the project is to identify early biological indicators to predict the effects of non-genotoxic carcinogens
Non-invasive diagnostic approach to determine patient risk from tumor metastasis based on circulating tumor cells. Individual therapy success and survival rate of tumor patients depend to a large exte
Early detection of negative effects of immunotherapeutic drug substances using innovative, highly complex, human organotypical co-culture systems combined with systems biology-based signaling pathway
Stillbirths are often referred to as a "silent epidemic" and are among the leading causes of death worldwide - 4 babies are lost every minute. The vast majority of stillbirths (98%) occur in low- and
Researchers led by Dr. Michael Pawlak from NMI TT GmbH and Prof. Dr. Hans Neubauer from the Women's Clinic at the University of Düsseldorf have developed a new method that enables a more precise analy
“Leveraging innovative Research Tools to meet public Health Challenges – EU BioMed21 Workshop Perspectives“ The biomedical research landscape is undergoing a transformative shift toward human-centric,
Tiny holes, big opportunities: a nanodiag BW project meeting took place at the NMI today. Presentations and discussions focused on production and applications. Tiny holes, great opportunities: Today (
